[DOI] [PMC free article] [PubMed] [Google Scholar] 138.Dhatariya K., Bain S.C., Buse J.B., Simpson R., Tarnow L., Kaltoft M.S., Stellfeld M., Torne K., Pratley R.E., LEADER Publication Committee on behalf of the LEADER Trial Investigators The Impact of Liraglutide on Diabetes-Related Foot Ulceration and Associated Complications in Patients with Type 2 Diabetes at High Risk for Cardiovascular Events: Results from the LEADER Trial
Participants who consistently hit 70 or more ounces of water daily had zero serious complications over 12 weeks of tracking
By improving lipid metabolism (lowering cholesterol) and lowering blood pressure, GLP-1 agonists contribute to cardiovascular health maintenance and disease prevention ( Nature )
Among the most groundbreaking of these medications is retatrutide , an investigational triple agonist peptide that targets not one, but three key metabolic hormone receptors
In the surgical recovery trials, ipamorelin was described as well-tolerated
Inactive: Cyanocobalamin is the synthetic form of vitamin B12